4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Q32 Bio Inc. (QTTB) operates in the Biotechnology industry and is headquartered in Waltham, United States with about 22 employees. Its market capitalization is roughly $447 million. In the fiscal year ended 2025-12-31, QTTB reported $54M in revenue and $30M in net income.
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.
Interactive charts & full statements → Open the QTTB valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $54M | $0M | ($7M) | $7M |
| Operating Income (EBIT) | $17M | ($66M) | ($48M) | ($39M) |
| Net Income | $30M | ($48M) | ($54M) | ($43M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $54M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($8M) | $46M | ($8M) | ($9M) | ($12M) | — |
| Net Income | ($8M) | $58M | ($7M) | ($10M) | ($11M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $62M | $92M | $47M | $62M | — |
| Total Liabilities | $20M | $87M | $230M | $192M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive QTTB viewer.
About TickerBase · Data methodology & sources